EIR Dow Pharmaceutical Sciences Feb 2012

William Millar FDA$595.00 - Available Now

FDA investigators audited the Dow Pharmaceutical Sciences - Petaluma, CA, United States facility and issued inspectional observation (via FDA 483) on 10 Feb 2012.

Product details

  • Category:
  • Inspection end: 10 Feb 2012
  • Location: Petaluma, United States
  • FEI: 1000135370
Add To Cart